$IQST~~From Acquisitions To Organic Growth, IQSTEL Gets

New Post Public Reply Private Reply Replies (0) Message Board
Golden Cross
79
$IQST~~From Acquisitions To Organic Growth, IQSTEL Gets Closer To $1 Billion Revenue Target For 2027 – Company To Deliver 500K In Dividends This Year
???? https://www.benzinga.com/partner/news/25/11/4...27-company

IQSTEL Inc. (NASDAQ:IQST), a global connectivity, AI and digital company focused on diversifying its revenue stream, expects double-digit organic revenue growth in 2026, with 26% topline growth.

The company, which has grown over the years through a combination of 12 strategic acquisitions – it has made 12 since 2018 – and operational excellence, has businesses in telecommunication, fintech and artificial intelligence, all of which it says are seeing rapid, transformational growth. IQSTEL is targeting 2026 organic revenue of $430 million, up 26% from the $340 million it expects to earn this year. Last year, IQSTEL posted revenue of $283 million. The company noted that it has a strong track record of meeting or exceeding its financial forecasts as well as demonstrating consistent execution and disciplined management across its diversified operations and that shouldn't change.

Making Buys, Growing Sales
Since its launch in 2018, IQSTEL has completed 12 strategic acquisitions, shaping a diversified revenue stream that is now approximately 80% telecommunications and 20% fintech. The company also acquired Reality Border, an AI firm that now serves as IQSTEL's R&D division, focused on developing proprietary AI-driven solutions. IQSTEL's acquisition strategy is far from over — the company plans to acquire two to three additional accretive businesses as part of its roadmap to achieve $15 million in EBITDA by 2026, while maintaining a strong focus on profitable organic growth.

“Our forecast reflects the strength of our business platform and our ability to deliver consistent, organic growth while preparing for high-margin expansion,” said Leandro Iglesias, CEO of IQSTEL. “We are building toward a balanced model of growth that combines innovation, efficiency, and scale — positioning IQSTEL for sustained profitability and long-term shareholder value.” Once the company completes any deals it will update its 2026 revenue target. It is also still on the path to its stated goal of achieving revenue of $1 billion by 2027.

Getting Into Cybersecurity By Way Of Cycurion
While acquisitions are a big part of IQSTEL's growth story, the company is also striking partnerships and alliances that could help it boost sales and get love from Wall Street. One in particular partnership that could do that is a recent deal with AI cybersecurity company Cycurion Inc. (NASDAQ:CYCU), which gives IQSTEL entrance into another red-hot area: cybersecurity. This summer the two teamed up to create and sell AI cybersecurity products and solutions for the global telecommunications and enterprise markets. It marked IQSTEL's entry into AI cybersecurity and marks a new, potentially high-margin revenue stream for the company.

As part of the collaboration the two signed a Memorandum of Understanding (MOU) to become mutual equity partners following a planned $1 million stock exchange. Both parties also agreed to deliver a $500,000 dividend to their shareholders by December 31, 2025. Each company may satisfy this dividend obligation either in its own stock or in shares received from the stock exchange.

IQSTEL said the deal is designed to unlock shareholder value, while being strategically timed for both companies as the products and services of IQSTEL and Cycurion are largely insulated from potential disruptions caused by changes in U.S. tariffs and their economic consequences. The deal gives IQSTEL access to Cycurion's presence in the U.S. market and deep relationships within government and institutional sectors while Cycurion gets access to IQSTEL's global telecommunications customer base. The goal is for the companies to cross-sell solutions, penetrate new markets and open revenue streams that neither could fully capture alone.

“We are very excited to add cybersecurity to our portfolio of products,” said Iglesias. “This partnership with Cycurion, whose specialized solutions are trusted by the U.S. government, not only broadens our capabilities but also enhances the trust we bring to our global telecom and enterprise customers. Our plan is to officially launch these new cybersecurity solutions at the largest global telecom event in 2026.”

Wall Street On Board?
It's not only IQSTEL and Cycurion that are hopeful about the collaboration. Litchfield Hills, which has a buy rating and $18 price target on IQSTEL, said the structure of the deal ensures that both companies have skin in the game and increases the odds of it being executed meaningfully rather than being just a symbolic arrangement. The Wall Street firm said the Cycurion deal and IQSTEL's focus on cybersecurity complement its push into fintech with its purchase of Globetopper.

"By pairing cybersecurity (through Cycurion) with fintech (through GlobeTopper), iQSTEL is broadening its high-margin service suite to telecom partners. That better positions it to increase revenue and EBITDA and deepen partnerships rather than relying solely on connectivity services," wrote Litchfield Hills analyst Barry Sine in the research report. "We view the iQSTEL–Cycurion alliance as a strategic lever with asymmetric upside, not just another marketing tie-up."

IQSTEL takes its goal to reach $1 billion in revenue by 2027 very seriously. It's already on the path to achieve that with its revenue target set for 2026 and its entrance into cybersecurity thanks to its alliance with Cycurion. With that coming online in 2026 and more acquisitions slated for the New Year, there's a lot more connections in store for this global connectivity, AI and digital company.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ABnet Touts Anthropic's AI in Corporate Evolution

Updated Category News Views 7

Changing the AI Game in Enterprise At the heart of Tel Aviv-Yafo, ABnet Communication Ltd. is spitting fire, and this ain't your average tech chatter. They're drilling right down to the marrow, stressing just how much Anthropic—kingpin of advanced AI for enterprises—is shaking up the corporate shell game. Today’s conversation leans heavily into autonomous AI, and...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 3

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 3

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
TerraMaster 725 NAS Unveils AI-Era Storage Solutions

Updated Category News Views 3

Tech Giants and Pioneers Rejoice Strap in, because TerraMaster just waved the green flag on their brand-new 725 Series Xeon Rackmount NAS, and it's high time the data storage world got a shake-up. Picture this: we're in the throes of an AI boom, and companies have data needs that gobble up yesterday's solutions with the hunger of a black hole. Well, enter TerraMaster's...

Continue Reading
ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 2

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 3

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
Handshake Introduces AI Skills Studio at NYSE Event

Updated Category News Views 5

Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...

Continue Reading
GRAI's Innovative Play with Hangout FM in Streaming

Updated Category News Views 4

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Continue Reading
FBI Vet Marcus Thomas Joins Re-fined Nonprofit Board

Updated Category News Views 3

Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...

Continue Reading
Gun Violence Expo Aims for National Impact in Chicago

Updated Category News Views 4

Converging Minds at the Chicago Gun Violence Expo In a city known for its resilience amid diverse challenges, the National Gun Violence Prevention Expo is stepping into the spotlight. With all eyes on Chicago from September 24 to 26, this isn't just another event—it’s a clarion call for action. Uniting Influential Voices When you've got former NFL stars like Matt...

Continue Reading

Top 5 Most Recently Viewed Articles

Health Canada Greenlights Bylvay™ for Alagille Syndrome Relief

Updated Category News Views 132

Health Canada's Approval of Bylvay™ for Alagille Syndrome Bylvay™ is a groundbreaking medication that has recently received approval from Health Canada, becoming the first of its kind to treat both Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis. This approval is particularly significant as it offers hope to patients aged 12 months and older who...

Continue Reading
Delta Airlines Faces Turbulence Amid Legal Challenges Ahead

Updated Category News Views 270

Delta Airlines Climbs in Pre-Market Trading Delta Air Lines, Inc. (NYSE: DAL) experienced a notable 2.61% increase in pre-market trading. This rise follows the airline's recent decision to take legal action against Crowdstrike Inc. (NASDAQ: CRWD), marking significant developments for both companies. Market Performance Overview Delta Airlines' stock was quoted at $55.34,...

Continue Reading
Warner Bros Discovery Gains Favor While Fox Corp Faces Downgrade

Updated Category News Views 103

Warner Bros Discovery Receives Upgraded Rating MoffettNathanson has recently made headlines by upgrading Warner Bros Discovery Inc (NASDAQ: WBD) from a 'Neutral' to a 'Buy' rating. This significant change in outlook is driven by enhancements in the company's financial stability, impressive growth at Max, and the alleviation of various studio challenges. Positive Financial...

Continue Reading
Allarity Therapeutics Doses Second Patient in Ovarian Cancer Trial

Updated Category News Views 109

Advancing Treatment Options with Stenoparib Allarity Therapeutics, Inc. (NASDAQ: ALLR), a prominent name in the biopharmaceutical industry, has set a significant milestone by dosing its second patient in a Phase 2 clinical trial. This trial aims to explore the efficacy of stenoparib, a dual PARP and WNT pathway inhibitor, for individuals battling advanced ovarian cancer...

Continue Reading
NOTÖRIOUS Unleashes Debut EP 'Live It Up' with Heavy Sound

Updated Category News Views 222

NOTÖRIOUS Launches 'Live It Up' with a Self-Titled EP With their new single "Live It Up" and a self-titled EP that carries their name with pride, NOTÖRIOUS proves that rock is far from being dormant. The group, renowned for their vibrant energy and explosive performances, is infusing glam metal with their distinctive sound. The Spirit of Glam Metal is Alive "Tonight's...

Continue Reading